The association between RAD18 Arg302Gln polymorphism and the risk of human non-small-cell lung cancer
β Scribed by Hirotaka Kanzaki; Mamoru Ouchida; Hiroko Hanafusa; Hiromasa Yamamoto; Hiromitsu Suzuki; Masaaki Yano; Motoi Aoe; Kazue Imai; Hiroshi Date; Kei Nakachi; Kenji Shimizu
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 366 KB
- Volume
- 134
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Lung cancer is one of the leading causes of cancer death worldwide. Tobacco smoking is the main risk factor for lung cancer. Less than 20% of smokers develop lung cancer in their lifetime, however, indicating individual variations in lung cancer risk. Proβinflammatory cytokines produced
Human non-small-cell lung cancer (NSCLC) is considered to be a chemotherapy-refractory malignancy. The underlying mechanisms remain rather obscure. The multidrug resistanceassociated protein (MRP), mediating a multidrug resistance (MDR) phenotype, has been reported to be overexpressed in several dru